The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Mar. 01, 2022
Filed:
Oct. 05, 2021
Applicant:
Genmab A/s, Copenhagen V, DK;
Inventors:
Louise Koopman, Utrecht, NL;
Patrick Engelberts, Amersfoort, NL;
Dennis Verzijl, Amstelveen, NL;
Edward N. Van Den Brink, Halfweg, NL;
Rik Rademaker, Utrecht, NL;
Sieto Bosgra, Amsterdam, NL;
Frederikke L. Egerod, Copenhagen, DK;
David Satijn, Nieuwegein, NL;
Esther C. W. Breij, Driebergen, NL;
Assignee:
GENMAB A/S, Copenhagen V, DK;
Primary Examiner:
Int. Cl.
CPC ...
C07K 16/00 (2006.01); C07K 16/28 (2006.01); A61P 35/00 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
C07K 16/2827 (2013.01); A61P 35/00 (2018.01); C07K 16/2809 (2013.01); A61K 2039/505 (2013.01); C07K 2317/21 (2013.01); C07K 2317/24 (2013.01); C07K 2317/31 (2013.01); C07K 2317/92 (2013.01);
Abstract
The present invention relates to antibodies binding to B7H4, including bispecific antibodies binding to B7H4 and CD3. The invention further provides pharmaceutical compositions comprising the antibodies and use of the antibodies for therapeutic and diagnostic procedures, in particular in cancer therapy.